scorecardresearch
Business Today
Subscribe
PMS Today Immersives Economic Indicators UPSTART India Weather NRI
BT Golf BT Golf BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
News
MARKETS
IPO Corner

Feedback

IPO Corner

Kataria Industries is looking to raise Rs 54.58 crore via its SME issue, which entirely consists of a fresh issue of up to 56.85 lakh equity shares.
Updated : Jul 16, 2024

Kataria Industries IPO opens today: Check price band, GMP and other details of this SME Issue

Kataria Industries has two manufacturing plants in Ratlam, Madhya Pradesh, equipped with essential machinery, infrastructure, and in-house testing facilities.

The IPO of Sai Life Sciences include a fresh share sale of up to 800 crore, said the DRHP, which was filed on Friday, July 12, 2024.
Updated : Jul 15, 2024

TPG-backed Sai Life Science files DRHP with Sebi to launch IPO

The issue of Sai Life Sciences includes an offer-for-sale of up to 6,15,73,120 equity shares by its promoters and existing shareholders of the company. 

DAM Capital Advisors and SBI Capital Markets are the book running lead managers of the Bansal Wire IPO, while Kfin Technologies is the registrar for the issue.
Updated : Jul 10, 2024

Bansal Wire IPO shares to debut at stock markets today; what GMP signals for listing

Shares of Bansal Wire Industries were commanding a grey market premium (GMP) of Rs 76 apiece, when the issue had closed for the bidding.

Shares of companies including Crompton Greaves Consumer Electricals, Mphasis, Wheels India will trade ex-split on the trading session on Wednesday.
Updated : Jul 10, 2024

Stocks in news: Adani Power, Infosys, RVNL, Adani Ports, Mphasis, Delhivery, Mankind and Delta Corp

Stocks including Adani Power, Infosys, Adani Ports, Mphasis, Delta Corp, Aarti Drugs, RVNL, Phoenix Mills and more may remain under spotlight before the opening bell on Wednesday, July 10.

Emcure Pharma develops, manufactures, and globally markets a wide range of pharmaceutical products across several major therapeutic areas.
Updated : Jul 10, 2024

Emcure Pharma IPO shares to make stock market debut today; strong listing gains likely

Shares of Emcure Pharma were commanding a grey market premium of Rs 390-400 on the last day of the bidding for the issue, before the allotment was announced.

DAM Capital Advisors and SBI Capital Markets are the book running lead managers of the Bansal Wire IPO, while Kfin Technologies is the registrar for the issue.
Updated : Jul 09, 2024

Bansal Wire IPO shares to list tomorrow; should you expect a strong listing pop?

The IPO of New Delhi-based Bansal Wire was open for bidding between July 03 and July 05, which offered its shares in the fixed price band of Rs 243-256 per share with a lot size of 58 shares.

Emcure Pharma develops, manufactures, and globally markets a wide range of pharmaceutical products across several major therapeutic areas.
Updated : Jul 09, 2024

Emcure Pharma to make stock market debut on Wednesday; here's what to expect as GMP corrects

The IPO of Emcure Pharma was open for bidding July 03 and July 05, where the Pune-based company offered its shares in the price band of Rs 960-1,008 apiece with a lot size of 14 shares.

According to Sebi, the overall derivative turnover has jumped to Rs 500 lakh crore in FY24 from Rs 210 lakh crore in FY18.
Updated : Jul 09, 2024

Sebi committee bats for higher lot size, limited weekly contracts to curb F&O volatility

There are ample instances and evidence, which suggest that many novice individuals borrow money to trade options, to mint a quick buck from the highly risky F&O market.

Ambey Laboratories manufactures agrochemical products for crop protection. The company has been serving the agrochemical sector for almost four decades.
Updated : Jul 09, 2024

Ambey Labs IPO allotment: Check application status, latest GMP and listing date

The SME IPO of Ambey Laboratories was open for bidding July 04 and July 08. The New Delhi-based company had sold its shares in the price band of Rs 65-68 per share with a lot size of 2,000 shares.

The price band for Hyundai Motors India has not been announced yet but the company is likely to raise about Rs 25,000 crore from its initial stake sale.
Updated : Jul 08, 2024

Hyundai Motors IPO: Analysts decode likely price band, valuations, issue size m-cap & more

Gurugram-based Hyundai Motors India is a local subsidiary of Korea's Hyundai Motor Company, wherein the promoter is looking to offload 14.22 crore shares or 17.5 per cent stake of the company.

DAM Capital Advisors and SBI Capital Markets are the book running lead managers of the Bansal Wire IPO, while Kfin Technologies is the registrar for the issue.
Updated : Jul 08, 2024

Bansal Wire Industries IPO allotment: Check application status as GMP rises

The IPO of New Delhi-based Bansal Wire was open for bidding between July 03 and July 05, which offered its shares in the fixed price band of Rs 243-256 per share with a lot size of 58 shares.

Axis Capital, Kotak Mahindra Capital, JP Morgan India and Jefferies India are the book running lead managers of the Emcure Pharma IPO.
Updated : Jul 08, 2024

Emcure Pharma IPO allotment: Check application status, latest GMP and listing date

The IPO of Pune-based Emcure Pharma was open for bidding July 03 and July 05, which offered its shares in the fixed price band of Rs 960-1,008 per share with a lot size of 14 shares.

Bansal Wire Industries raised Rs 223.5 crore through anchor investors as it allocated 87,30,468 equity shares at a price of Rs 256 apiece.
Updated : Jul 05, 2024

Bansal Wire IPO subscribed 33 times on Day 3 so far; GMP rises as QIB portion booked 63x

The New Delhi-based Bansal Wire Industries is selling its shares in the price band of Rs 243-256 apiece. Investors can apply for a minimum of 58 shares and its multiples thereafter.

Emcure Pharma has raised Rs 582.6 crore via an anchor book as it allocated 57,79,850 shares to anchor investors at Rs 1,008 apiece.
Updated : Jul 05, 2024

Emcure Pharma IPO subscribed 33 times on Day 3 so far; QIBs lead bidders

The Pune-based Emcure Pharma is selling its shares in the price band of Rs 960-1,008 apiece. Investors can apply for a minimum of 14 shares and its multiples thereafter.

The listing price of a debutant stock on NSE Emerge platform cannot be listed at a premium more than 90 per cent over its issue price.
Updated : Jul 05, 2024

Nephro Care IPO GMP at 200% but stock may not list above Rs 171 apiece today. Here's why

The grey market premium (GMP) for Nephro Care India was last seen at Rs 175 apeice, suggesting a listing pop of nearly 200 per cent for the investors.

Emcure Pharma IPO: The category for retail investors was subscribed 3.43 times, while the quota reserved for non-institutional investors saw a subscription of 13.67 times.
Updated : Jul 04, 2024

Emcure Pharma IPO subscribed 4.98 times on Day 2; check latest GMP & other key details

Emcure Pharma IPO: As per BSE data available on Thursday, investors placed their bids for 6,82,10,940 equity shares, or 4.98 times, compared to 1,37,03,538 equity shares offered for subscription. The three-day bidding will conclude on July 5 (Friday).

Market participants have welcomed the move by the leading Mumbai-based bourse, and said that the move will limit the scope of speculation in the SME space.
Updated : Jul 04, 2024

SME IPO: NSE caps listing gains to 90%; here's what it means for investors

NSE announced to introduce an overall capping of 90 per cent on the opening price or equilibrium price discovered during a special pre-open session for IPO on the NSE Emerge platform.

Bansal Wire Industries raised Rs 223.5 crore through anchor investors as it allocated 87,30,468 equity shares at a price of Rs 256 apiece.
Updated : Jul 04, 2024

Bansal Wire Industries IPO subscribed 4.2 times on Day 2 so far; GMP takes a hit

The New Delhi-based Bansal Wire Industries is selling its shares in the price band of Rs 243-256 apiece. Investors can apply for a minimum of 58 shares and its multiples thereafter.

Emcure Pharma has raised Rs 582.6 crore via an anchor book as it allocated 57,79,850 shares to anchor investors at Rs 1,008 apiece.
Updated : Jul 04, 2024

Emcure Pharma IPO subscribed 3.36 times on Day 2 so far; GMP inches higher

The Pune-based Emcure Pharma is selling its shares in the price band of Rs 960-1,008 apiece. Investors can apply for a minimum of 14 shares and its multiples thereafter.

SME IPO: The circular will come in force with immediate effect i.e. 4th July 2024. The fresh move is made to standardise the opening price discovery and equilibrium price across exchanges.
Updated : Jul 04, 2024

SME IPO: NSE Emerge puts 90% cap on listing price of issues; key details 

To be sure, the price control cap of 90 per cent would be applicable only to the SME segment and not for mainboard IPOs, relisted securities or public debt, NSE said in a circular. 

Ambey Laboratories, incorporated in 1985, manufactures agrochemical products for crop protection, serving the agrochemical sector for almost four decades.
Updated : Jul 04, 2024

Ambey Labs IPO opens today: Check price band, GMP, lot size and more

Investors can apply for a minimum of 2,000 equity shares and its multiples thereafter. Each lot of the issue cost Rs 1.36 lakh to the investors.

Load More

HOT STOCKS

  • NSE
  • BSE
Most active stocks that’s creating maximum buzz in the share market

TOP VIDEOS

Advertisement